A Phase 1/2a Study of BMS-986253 in Combination
with Nivolumab in Advanced Cancers, NCT03400332
PURPOSE OF THIS CLINICAL RESEARCH TRIAL
The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab in patients with advanced cancers.
MORE DETAILS ON THIS TRIAL
18020 / NCT03400332 / Open 6-20-2018 / On-Hold 6-20-2019 / CALL PM 9-16-2019
TRIAL AVAILABLE AT THESE LOCATIONS
CALL PM 9-16-2019